OladimejiAkinboroMD

Hematology/Oncology

Hematology/Oncology Fellow

Dr. Akinboro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Boston Medical Center
Section of Hematology/Oncology, FGH Building, 1st Floor
Boston, MA 02118

Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Chief Residency, Internal Medicine, 2016 - 2017
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2013 - 2016
University of Ilorin Faculty of Health SciencesClass of 2006

PubMed

7 citations
Electronic Cigarette Use among Survivors of Smoking-Related Cancers in the United States.
Oladimeji Akinboro, Stanley Madu Nwabudike, Rawad Elias, Oluseyi Balasire, Olatunde Ola
Cancer Epidemiology, Biomarkers & Prevention. 2019-09-09
61 citations
FDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations
Luckson Mathieu, Erin Larkins, Oladimeji Akinboro, Pourab Roy, Anup K. Amatya
Clinical Cancer Research. 2021-08-03
39 citations
FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as Single Agents for First-Line Treatment of Advanced/Metastatic PD-L1-High NSCLC.
Oladimeji Akinboro, Erin Larkins, Lee H Pai-Scherf, Luckson N Mathieu, Yi Ren
Clinical Cancer Research. 2022-06-01

Lectures

Contemporary patterns of racial/ethnic disparities in surgical treatment and overall survival for localized resectable non-small cell lung cancer in the United States.
2019 ASCO Annual Meeting - 6/1/2019
E-cigarette use among patients of smoking-related cancers in the United States.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Adding Chemotherapy to Immunotherapy Improves Survival in Advanced Non-Small Cell Lung CancerJune 5th, 2021
Secondhand Smoke Exposure in Cancer Survivors Remains HighSeptember 10th, 2017
Secondhand Smoke Exposure in Cancer Survivors Remains HighSeptember 10th, 2017
Join now to see all